doi: 10.7326/0003-4819-137-8-200210150-00014.
New federal initiatives to enhance the medical treatment of opioid dependence
Affiliations
- PMID: 12379070
- DOI: 10.7326/0003-4819-137-8-200210150-00014
Item in Clipboard
New federal initiatives to enhance the medical treatment of opioid dependence
Ann Intern Med.
.
Abstract
Opioid dependence is a chronic relapsing medical condition with substantial health and societal complications. Recent federal initiatives are designed to enhance the medical treatment of patients with opioid dependence and will expand the role of internists in the care of these patients. These initiatives include a process for federal exemptions to allow for pharmacologic treatment in office settings, waivers for the use of new medications, and new rules governing the oversight and distribution of opioid agonist medications for maintenance treatment. This perspective describes these initiatives and their implications for internists.
Similar articles
-
Federal plan for prescriber education on opioids misses opportunities.Ann Intern Med. 2012 Aug 7;157(3):205-6. doi: 10.7326/0003-4819-157-3-201208070-00448. Ann Intern Med. 2012. PMID: 22868838 No abstract available.
-
Public policy statement on Office-Based Opioid Agonist Treatment (OBOT).J Addict Dis. 2005;24(3):153-61. doi: 10.1300/J069v24n03_12. J Addict Dis. 2005. PMID: 16186090 No abstract available.
-
Healthcare Reform. Opioid Crisis.Issue Brief Health Policy Track Serv. 2018 Dec 24;2018:1-89. Issue Brief Health Policy Track Serv. 2018. PMID: 30681792 No abstract available.
-
The US Opioid Crisis: Current Federal and State Legal Issues.Anesth Analg. 2017 Nov;125(5):1675-1681. doi: 10.1213/ANE.0000000000002403. Anesth Analg. 2017. PMID: 29049113 Review.
-
Consensus statement on office-based treatment of opioid dependence using buprenorphine.J Subst Abuse Treat. 2004 Sep;27(2):153-9. doi: 10.1016/j.jsat.2004.06.005. J Subst Abuse Treat. 2004. PMID: 15450648 Review.
Cited by
-
Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods.Contemp Clin Trials. 2017 Sep;60:105-112. doi: 10.1016/j.cct.2017.07.006. Epub 2017 Jul 8. Contemp Clin Trials. 2017. PMID: 28689852 Free PMC article.
-
Selective review and commentary on emerging pharmacotherapies for opioid addiction.Subst Abuse Rehabil. 2011 Oct 28;2:181-8. doi: 10.2147/SAR.S22782. eCollection 2011. Subst Abuse Rehabil. 2011. PMID: 24474855 Free PMC article. Review.
-
Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.Ann Fam Med. 2007 Mar-Apr;5(2):146-50. doi: 10.1370/afm.665. Ann Fam Med. 2007. PMID: 17389539 Free PMC article. Clinical Trial.
-
Integrating medical care and addiction treatment.J Gen Intern Med. 2003 Jan;18(1):68-9. doi: 10.1046/j.1525-1497.2003.t01-1-21111.x. J Gen Intern Med. 2003. PMID: 12534767 Free PMC article. No abstract available.
-
A 5-year evaluation of a methadone medical maintenance program.J Subst Abuse Treat. 2006 Dec;31(4):433-8. doi: 10.1016/j.jsat.2006.05.018. Epub 2006 Sep 7. J Subst Abuse Treat. 2006. PMID: 17084798 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
